Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks)

Hypogalactia has a relative high frequency in women having delivered preterm infants, who often have difficulties in maintaining a sufficient production of milk for their infants’ needs over prolonged periods of time. Recent studies have shown a potential galactogogue effect of silymarin on milk pro...

Full description

Bibliographic Details
Main Authors: Chiara Peila, Alessandra Coscia, Paola Tonetto, Elena Spada, Silvano Milani, Guido Moro, Carlotta Fontana, Liliana Vagliano, Claudia Tortone, Elisa Di Bella, Enrico Bertino
Format: Article
Language:English
Published: PAGEPress Publications 2015-12-01
Series:La Pediatria Medica e Chirurgica
Subjects:
Online Access:http://www.pediatrmedchir.org/index.php/pmc/article/view/105
_version_ 1819238263234232320
author Chiara Peila
Alessandra Coscia
Paola Tonetto
Elena Spada
Silvano Milani
Guido Moro
Carlotta Fontana
Liliana Vagliano
Claudia Tortone
Elisa Di Bella
Enrico Bertino
author_facet Chiara Peila
Alessandra Coscia
Paola Tonetto
Elena Spada
Silvano Milani
Guido Moro
Carlotta Fontana
Liliana Vagliano
Claudia Tortone
Elisa Di Bella
Enrico Bertino
author_sort Chiara Peila
collection DOAJ
description Hypogalactia has a relative high frequency in women having delivered preterm infants, who often have difficulties in maintaining a sufficient production of milk for their infants’ needs over prolonged periods of time. Recent studies have shown a potential galactogogue effect of silymarin on milk production in animal models (cows and rats) and in humans (mothers of term newborns); nonetheless, none of the studies conducted on humans consisted of double-blind randomized clinical trials and no data are available concerning mothers who delivered preterm infants. The aim of our study was to assess the efficacy of silymarin (BIO-C®) as galactogogue and its tolerability in mothers who delivered preterm infants. We enrolled 50 mothers at 10±1 days post-partum who had delivered infants at ® and placebo arms. No adverse events were observed in the 2 arms among mothers and infants, and silymarin and its metabolites were not detectable in the analyzed human milk samples. Further investigation on specific patient groups affected by hypogalactia, defined according to stricter criteria, should be planned to assess the efficacy of the product in increasing milk production.
first_indexed 2024-12-23T13:33:27Z
format Article
id doaj.art-01c52fd673f34f82b4ea900fe40ed230
institution Directory Open Access Journal
issn 0391-5387
2420-7748
language English
last_indexed 2024-12-23T13:33:27Z
publishDate 2015-12-01
publisher PAGEPress Publications
record_format Article
series La Pediatria Medica e Chirurgica
spelling doaj.art-01c52fd673f34f82b4ea900fe40ed2302022-12-21T17:45:04ZengPAGEPress PublicationsLa Pediatria Medica e Chirurgica0391-53872420-77482015-12-0137310.4081/pmc.2015.105114Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks)Chiara Peila0Alessandra Coscia1Paola Tonetto2Elena Spada3Silvano Milani4Guido Moro5Carlotta Fontana6Liliana Vagliano7Claudia Tortone8Elisa Di Bella9Enrico Bertino10Neonatology Unit, Department of Public Health and Pediatrics, University of Turin, TurinNeonatology Unit, Department of Public Health and Pediatrics, University of Turin, TurinNeonatology Unit, Department of Public Health and Pediatrics, University of Turin, TurinUnit of Medical Statistics and Biometry, Department of Clinical Sciences and Community Health, University of Milan, MilanUnit of Medical Statistics and Biometry, Department of Clinical Sciences and Community Health, University of Milan, MilanItalian Association of Human Milk Banks, MilanNeonatology Unit, Department of Public Health and Pediatrics, University of Turin, TurinNeonatology Unit, Department of Public Health and Pediatrics, University of Turin, TurinNeonatology Unit, Department of Public Health and Pediatrics, University of Turin, TurinNeonatology Unit, Department of Public Health and Pediatrics, University of Turin, TurinNeonatology Unit, Department of Public Health and Pediatrics, University of Turin, TurinHypogalactia has a relative high frequency in women having delivered preterm infants, who often have difficulties in maintaining a sufficient production of milk for their infants’ needs over prolonged periods of time. Recent studies have shown a potential galactogogue effect of silymarin on milk production in animal models (cows and rats) and in humans (mothers of term newborns); nonetheless, none of the studies conducted on humans consisted of double-blind randomized clinical trials and no data are available concerning mothers who delivered preterm infants. The aim of our study was to assess the efficacy of silymarin (BIO-C®) as galactogogue and its tolerability in mothers who delivered preterm infants. We enrolled 50 mothers at 10±1 days post-partum who had delivered infants at ® and placebo arms. No adverse events were observed in the 2 arms among mothers and infants, and silymarin and its metabolites were not detectable in the analyzed human milk samples. Further investigation on specific patient groups affected by hypogalactia, defined according to stricter criteria, should be planned to assess the efficacy of the product in increasing milk production.http://www.pediatrmedchir.org/index.php/pmc/article/view/105Human milkGalactogoguesPreterm newbornBreastfeeding
spellingShingle Chiara Peila
Alessandra Coscia
Paola Tonetto
Elena Spada
Silvano Milani
Guido Moro
Carlotta Fontana
Liliana Vagliano
Claudia Tortone
Elisa Di Bella
Enrico Bertino
Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks)
La Pediatria Medica e Chirurgica
Human milk
Galactogogues
Preterm newborn
Breastfeeding
title Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks)
title_full Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks)
title_fullStr Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks)
title_full_unstemmed Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks)
title_short Evaluation of the galactogogue effect of silymarin on mothers of preterm newborns (<32 weeks)
title_sort evaluation of the galactogogue effect of silymarin on mothers of preterm newborns 32 weeks
topic Human milk
Galactogogues
Preterm newborn
Breastfeeding
url http://www.pediatrmedchir.org/index.php/pmc/article/view/105
work_keys_str_mv AT chiarapeila evaluationofthegalactogogueeffectofsilymarinonmothersofpretermnewborns32weeks
AT alessandracoscia evaluationofthegalactogogueeffectofsilymarinonmothersofpretermnewborns32weeks
AT paolatonetto evaluationofthegalactogogueeffectofsilymarinonmothersofpretermnewborns32weeks
AT elenaspada evaluationofthegalactogogueeffectofsilymarinonmothersofpretermnewborns32weeks
AT silvanomilani evaluationofthegalactogogueeffectofsilymarinonmothersofpretermnewborns32weeks
AT guidomoro evaluationofthegalactogogueeffectofsilymarinonmothersofpretermnewborns32weeks
AT carlottafontana evaluationofthegalactogogueeffectofsilymarinonmothersofpretermnewborns32weeks
AT lilianavagliano evaluationofthegalactogogueeffectofsilymarinonmothersofpretermnewborns32weeks
AT claudiatortone evaluationofthegalactogogueeffectofsilymarinonmothersofpretermnewborns32weeks
AT elisadibella evaluationofthegalactogogueeffectofsilymarinonmothersofpretermnewborns32weeks
AT enricobertino evaluationofthegalactogogueeffectofsilymarinonmothersofpretermnewborns32weeks